Active Biotech AB Presents Data On Paquinimod At EULAR 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LUND, Sweden, June 11, 2014 (GLOBE NEWSWIRE) -- Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data related to the drug candidate paquinimod (57-57) for the treatment of systemic sclerosis, at the scientific conference "EULAR Annual European Congress of Rheumatology" held in Paris on June 11-14, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news